Surgery News and Research

RSS

Botox beneficial for cosmetic dental treatment

A significant majority of dental implant patients are older with facial aging and their dentists may need to consider the benefits of rejuvenation techniques, such as Botox, for maximizing the cosmetic outcomes of the procedure, according to a leading cosmetic surgeon speaking at the American Academy of Implant Dentistry annual meeting.

25 Oct 2010

WallFlex Biliary RX Stent receives CE Mark approval for benign biliary strictures

Boston Scientific Corporation today announced that its WallFlex Biliary RX Fully Covered Stent has received CE Mark approval for the treatment of benign biliary strictures.

25 Oct 2010

$Cedars-Sinai to develop world's first biological treatment for compression fractures$

Cedars-Sinai to develop world's first biological treatment for compression fractures

A team of physicians and scientists from the Cedars-Sinai Regenerative Medicine Institute and Department of Surgery, led by Dan Gazit, DMD, PhD has been awarded a three-year $1.9 million grant from the California stem cell agency to fund research leading to clinical trials for what could become the first biological treatment for the most common type of bone fracture in osteoporosis patients.

25 Oct 2010

Revance presents results of RT001 two Phase 2b clinical trials for lateral canthal lines at Chicago annual meeting

Revance Therapeutics, Inc. today announced that the results of two Phase 2b clinical trials on RT001, a topical botulinum toxin type A which is under investigation for the treatment of lateral canthal lines (crow's feet wrinkles) were presented at the annual meeting of the American Society of Dermatologic Surgery in Chicago.

25 Oct 2010

UCSF scientists receive grants to refine embryonic stem cell-based strategies for neurological diseases

UCSF scientists have received two grants from the California Institutefor Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure. The goal of the grants is for researchers to make significant strides toward the development of potential therapies within the next three years.

25 Oct 2010

Opinions: U.S. aid for Haiti delays; U.S. Medical Education Initiative

In a Washington Examiner opinion piece, Senator Tom Coburn (R-Okla.) writes about U.S. aid to Haiti and addresses allegations that he is holding up funding The situation in Haiti is confusing, but there are some things we know. First, we know that immediately after the earthquake the United States responded quickly and compassionately with aid and relief.

25 Oct 2010

Hepatitis C from anesthetist case assumes new proportions

According to Victoria’s chief health officer yesterday, another 1,100 people would be screened for hepatitis C that could have come from contact with an infected doctor at more than one clinic.

24 Oct 2010

New ear implant for Meniere’s disease

Meniere’s disease is a disease that affects the inner ear – a region responsible for balance. It affects 1% of Americans and can be quite disabling since it leads to attacks of vertigo. At present medications can not completely cure the condition and surgery is often unsuccessful.

24 Oct 2010

Transcend announces acquisition of Spryance

TRANSCEND SERVICES, INC. a leading provider of clinical documentation services to the U.S. healthcare market, announced today that it has acquired Spryance, Inc. and its subsidiaries on October 21, 2010.

22 Oct 2010

Study evaluates protective effect of airbags on kidneys, upper urinary tract

Occupants in motor vehicles with airbags are much less likely to suffer kidney or renal damage in a crash than are occupants in vehicles without airbags, according to a new study in the September Journal of the American College of Surgeons.

22 Oct 2010

New technology could prove effective in mentoring general surgeons in remote locations

Telementoring may be an effective way for subspecialist surgeons to assist remotely located general surgeons in the care of patients in need of emergency subspecialty surgical procedures, according to new research findings published in the September issue of the Journal of the American College of Surgeons.

22 Oct 2010

American Academy takes measures to attract women to become orthopaedic surgeons

Only 3.9 percent of orthopaedic surgeons and 13.8 percent of orthopaedic residents are women, according to the American Academy of Orthopaedic Surgeons. The academy is working to attract more women to the specialty by placing advertisements in medical student publications and sponsoring booths at medical student meetings.

22 Oct 2010

New guidelines feature various key updates for stroke or TIA survivors

Treating metabolic syndrome and undergoing carotid angioplasty may prevent recurrent stroke or transient ischemic attack, according to revised American Heart Association/American Stroke Association guidelines.

22 Oct 2010

Research suggests lowering cholesterol can reduce benign prostatic hyperplasia

A cholesterol-lowering drug reduced the enlarged prostates of hamsters to the same extent as a drug commonly used to treat benign prostatic hyperplasia (BPH), report researchers at Children's Hospital Boston and their colleagues in the October issue of the Journal of Urology. Together, the drugs worked even better.

22 Oct 2010

Researchers suggest gene therapy may treat patients with major depression

In a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional drug treatment.

22 Oct 2010

Orthopaedic Surgeon implants first MIDLINE device at Valley Hospital

Just days after Centinel Spine's new STALIF MIDLINE Integrated Interbody Fusion system was unveiled at the annual meeting of the North American Spine Society (NASS), the first MIDLINE device has been successfully implanted by noted Orthopaedic Surgeon, John S. Thalgott, MD at Valley Hospital in Las Vegas, NV.

22 Oct 2010

Oral cancer linked to oral sex: Study

Swedish researchers have found that the Human papillomavirus (HPV) that causes cervical cancer in women is also a risk factor for oropharyngeal squamous cell carcinoma (OSCC) or oral and throat cancer in men even if they do not smoke or consume alcohol.

21 Oct 2010

Boston Scientific's Advanix Biliary Plastic Stents receive FDA 510(k) clearance and CE Mark approval

Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix™ Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system. The product is now available in Europe and other international markets; the Company plans to launch it in the U.S. this quarter.

21 Oct 2010

PolyMedix plans PMX-60056 Phase 2 clinical trial in interventional cardiology

PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).

21 Oct 2010

Kensey Nash 2011 first quarter decreases 14% to $17.0 million

Kensey Nash Corporation , a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its first quarter ended September 30, 2010.

21 Oct 2010